References
- 1. WHO -Cardiovascular Diseases fact sheet
- 2. Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677-1684. doi:10.1001/jama.2011.52210.1001/jama.2011.522
- 3. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-37110.1161/01.CIR.77.2.361
- 4. Fishman RF, Kuntz RE, Carrozza JP, Jr, et al. Long-term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 1992;20:1101-10. 10.1016/0735-1097(92)90365-T10.1016/0735-1097(92)90365-T
- 5. Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8(10):E1150-E1162. doi:10.21037/jtd.2016.10.9310.21037/jtd.2016.10.93
- 6. Dorobantu M, Darabont RO, Badila E, Ghiorghe S. Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study. Int J Hypertens. 2010;2010:970694. Published 2010 Feb 1. doi:10.4061/2010/97069410.4061/2010/970694
- 7. Ma S, Yang D, Zhang X, Tang B, Li D, Sun M, et al. Comparison of restenosis rate with sirolimus-eluting stent in STEMI patients with and without diabetes at 6-month angiographic follow-up. Acta Cardiol. 2011;66(5):603–60610.1080/AC.66.5.2131085
- 8. Meijer A, Verheugt FWA, Werter CJPJ, Lie KI, Van Der Pol JML, Van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT study. Circulation.1993; 83:1524-1530.10.1161/01.CIR.87.5.1524
- 9. Cho JY. Identification of Risk Factors Influencing In-Stent Restenosis with Acute Coronary Syndrome Presentation. Chonnam Med J. 2017;53(3):203-210. doi:10.4068/cmj.2017.53.3.20310.4068/cmj.2017.53.3.203
- 10. Frierson JH, Dimas AP, Withlow PL, et al. Angioplasty of the proximal left anterior descending coronary artery: initial success and long-term follow-up. J Am Call Cardiol. 1992;19:745-751.10.1016/0735-1097(92)90512-L
- 11. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315–1323.10.1056/NEJMoa03507114523139
- 12. Nita D, Gurzun MM, Chiriac L, Cirstea AI, Parepa RI, Barbilian AG. Impact of stent diameter and length of instent restenosis after bare metal stent implantation. Romanian Biotechnological Letters, vol. 22, No. 2, 2017.
- 13. Abizaid A. Sirolimus-eluting coronary stents: a review. Vasc Health Risk Manag. 2007;3(2):191-201. doi:10.2147/vhrm.2007.3.2.19110.2147/vhrm.2007.3.2.191199403217580729
- 14. Sheiban I, Chiribiri A, Galli S, Biondi-Zoccai G, Montorsi P, Beninati S, Fabbiocchi F, Moretti C, Omedè P, Trabattoni D, Lotrionte M, Trevi GP, Bartorelli AL. Sirolimus-eluting stent implantation for bare-metal instent restenosis: is there any evidence for a late catch-up phenomenon? J Cardiovasc Med (Hagerstown). 2008 Aug;9(8):783-8. doi: 10.2459/JCM.0b013e3282fb7882. PMID: 18607241.10.2459/JCM.0b013e3282fb788218607241
- 15. Lee MS, Pessegueiro A, Zimmer R, Jurewitz D, Tobis J. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invasive Cardiol. 2008 Aug;20(8):401-403.